A modder named Safemilk has been working on an RTX remaster mod for Vampire: The Masquerade – Bloodlines that has just reached version 0.2 and had its first public release, an 8.5GB download that ...

Vampire: The Masquerade - Bloodlines is the latest game to get the RTX Remix treatment, and this impressive mod is also ...

Paradox Interactive opened up about the future of Vampire: The Masquerade - Bloodlines in an unusually frank interview, calling Bloodlines a "dead end" and saying that any potential Bloodlines 2 ...

Given that no previous Vampire: The Masquerade games are currently on Game Pass, however, we don't expect to see Bloodlines 2 on the library any time soon. There's good news for fans of developer ...

Vampire: The Masquerade – Bloodlines 2 won't be appearing in the first half of 2025. After so many delays, I have a feeling prospective bloodsuckers will already be pretty used to this.

I am far too excited for Vampire The Masquerade Bloodlines 2, and my Kindred heart skipped a beat during today's VTM Seattle By Night livestream.Welcome Phyre, the 17th-century Elder that we'll be ...

In the latest developer diary for Vampire: the Masquerade - Bloodlines 2, the discuss the rarely talked-about group: the mortals Published Sun, 02 Mar 2025 17:12:07 -0600 by Gavin Sheehan ...

Vampire: The Masquerade – Bloodlines 2 – The Music of Seattle. A key aspect of the music direction has therefore always been to develop strong, memorable themes for the main characters in ...

After numerous delays, Vampire: The Masquerade – Bloodlines 2 is finally giving fans a release date window later in 2025. Many had begun to give up hope after it seemed the game was stuck in ...

Ex-Dragon Age lead hopes Vampire: The Masquerade – Bloodlines 2 pulls an 'Expedition 33 or Baldur's Gate 3' by leaning into the combat-light, roleplaying-heavy gameplay of the tabletop version; ...

Vampire: The Masquerade – Bloodlines 2 is a first-person action role-playing video game developed by The Chinese Room and published by Paradox Interactive.